Vivani Medical, Inc.

Biotechnology • Healthcare • Alameda, CA, United States • VANI (NCM)

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.

415 506 8462 1350 South Loop Road, Alameda, CA 94502, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Insiders hold 43% of Vivani Medical, Inc. (NASDAQ:VANI), and they've been buying recently - Yahoo Finance

Yahoo Finance • Dec 5

Certain Stock Options of Vivani Medical, Inc. are subject to a Lock-Up Agreement Ending on 28-DEC-2025. - marketscreener.com

marketscreener.com • Dec 28

Vivani Medical Stock (VANI) Opinions on Insider Purchase - Quiver Quantitative

Quiver Quantitative • Oct 16

Should I hold or sell Vivani Medical Inc. stock in 2025 - Economic Data Impact & Free High Margin Investment Plays - bollywoodhelpline.com

bollywoodhelpline.com • Dec 25

Vivani Medical (VANI) Price Target Increased by 25.00% to 5.10 - Nasdaq

Nasdaq • Dec 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Vivani Medical, Inc. had layoffs?

No layoff events have been recorded for Vivani Medical, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Vivani Medical, Inc. have?

Vivani Medical, Inc. has approximately 37 employees.

What industry is Vivani Medical, Inc. in?

Vivani Medical, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Vivani Medical, Inc. a publicly traded company?

Yes, Vivani Medical, Inc. is publicly traded under the ticker symbol VANI on the NCM. The company has a market capitalization of approximately $0.09 billion.

Where is Vivani Medical, Inc. headquartered?

Vivani Medical, Inc. is headquartered in Alameda, CA, United States at 1350 South Loop Road, Alameda, CA 94502, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.